Ambev S.A. (NYSE:ABEV; BVMF:ABEV3) saw its ADRs decline 3.5% over the past week, closing Friday at $3.00, while shares traded in São Paulo ended at R$15.48, down 3.2%. The decline came even as the company reported normalized profit for the second quarter that beat pre-release consensus estimates by 16.2%, though revenue fell short by 2.6%.
The mixed results highlight a persistent concern for investors: while profitability exceeded expectations, operational metrics including volume, revenue, and EBITDA all came in below consensus. This divergence suggests that the company's bottom-line strength may not fully offset underlying operational softness.
Quarterly Performance Details
According to the company's report, second-quarter volume reached 39,727.9 thousand hectoliters, missing the consensus estimate of 40,500 by 1.9%. Net revenue totaled R$20,148.9 million, below the R$20,697 million expected, a 2.6% shortfall. Normalized EBITDA of R$6,376.7 million was slightly under the R$6,416 million consensus, a 0.6% miss. However, normalized profit came in at R$3,492.7 million, surpassing the R$3,007 million estimate by 16.2%.
The profit beat was largely attributed to a R$485.7 million reduction in net finance expenses, which nearly matched the R$487.9 million year-over-year decrease. Ambev did not provide a consensus figure for finance costs, so the comparison is not direct.
Operational Highlights
Despite the headline misses, the company's underlying operations remained robust. Organic revenue grew 6.1% year-over-year, while normalized EBITDA expanded 8.9%, with the margin improving by 80 basis points to 31.6%. Chief Executive Carlos Lisboa highlighted "another quarter of beer volume growth" and "solid top and bottom-line performance."
Brazil beer was the standout performer, with organic volume up 5.0%, revenue increasing 8.9%, and normalized EBITDA climbing 12.8%. However, non-alcoholic beverage volumes in Brazil declined 4.4%, and volumes in LAS and Canada also fell by 2.9% and 1.8%, respectively, indicating a mixed recovery across regions.
Cash Flow and Capital Returns
Cash conversion improved significantly, with operating cash flow surging 54.5% to R$4.71 billion. The board authorized approximately R$1.1 billion in interest on capital (IOC), underscoring the company's commitment to shareholder returns.
Market Context
The weekly decline was not solely company-specific. Ambev's movement closely tracked its domestic shares, Anheuser-Busch InBev (NYSE:BUD), which fell 3.1%, and the Ibovespa index, which dropped 3.1%. Heineken (AMS:HEIA) outperformed, slipping just 1.8%. Meanwhile, the S&P 500 gained 3.6%, meaning Ambev lagged the U.S. benchmark by 7.1 percentage points, despite its higher margins and improved cash flow.
Analyst Sentiment
Sell-side sentiment remains cautious. FactSet reports a Hold consensus from 19 active ratings, with an average price target of $3.23, implying a potential 7.7% upside from Friday's close. The number of Overweight ratings has declined to one from two three months ago, while Sell ratings increased to four from three. Price targets range from $2.60 to $4.00.
Upcoming Catalysts
Investors will watch Tuesday's release of minutes from Brazil's Copom meeting, following last week's Selic rate cut to 14%, and July inflation data (IPCA) due the same day. U.S. July CPI is scheduled for Wednesday. These releases could impact the Brazilian real and local discount rates, potentially affecting Ambev's valuation.
Ambev has not scheduled any company events this week, with its next earnings announcement set for October 29. In the meantime, analysts may adjust estimates following the mixed results, which could serve as a more immediate catalyst.
Risks and Outlook
Key risks include projected cash COGS per hectoliter for Brazil beer rising 4.5% to 7.5% this year, excluding third-party marketplace sales. The company also faces potential losses from a R$32.8 billion IOC-related uncertain tax treatment, for which no provision has been made. For a sustained rerating, investors may seek operational outperformance, which this quarter's EBITDA-level surprise did not fully deliver.
